Fabrazyme Infusion
Agalsidase beta
5mg
GENZYME EUROPE B.V.
| Pack size | 1 Glass Vial (Powder) |
|---|---|
| Dispensing mode | POM |
| Source | NETHERLANDS |
| Agent | GULF DRUG EST. |
| Retail Price | 2417.50 AED |
Available as:
Indications
Fabrazyme Infusion is used for:
For treatment of Fabry's disease (alpha-galactosidase A deficiency)
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Agalsidase beta :
Mechanism of Action
Alpha-galactosidase A catalyzes the hydrolysis of globotriaosylceramide (GL-3) and other a-galactyl-terminated neutral glycosphingolipids, such as galabiosylceramide and blood group B substances to ceramide dihexoside and galactose.
Note
Fabrazyme 5mg Infusion manufactured by GENZYME EUROPE B.V.. Its generic name is Agalsidase beta. Fabrazyme is availble in United Arab Emirates.
Farmaco UAE drug index information on Fabrazyme Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.